The Prostate Cancer Immune Microenvironment, Biomarkers and Therapeutic Intervention
Advanced prostate cancers have a poor survival rate and a lack of effective treatment options. In order to broaden the available treatments, immunotherapies have been investigated. These include cancer vaccines, immune checkpoint inhibitors, chimeric antigen receptor T cells and bispecific antibodie...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-04-01
|
| Series: | Uro |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-4397/2/2/10 |